-
Most Recent
Search Results
240 results for java
SAVA Stock: Two Dates Cassava Investors Need to Mark on Their Calendars
SAVA stock is flying upward today as investors clamor to hear information around two new products. Investors should save two upcoming dates.
Cassava Sciences Is on a Bumpy Road to Multibagger Status
Based on analyst estimates for the next ten years, SAVA stock could be worth three times more if its Alzheimer’s drug succeeds.
What the Latest Controversy Really Means for SAVA Stock
Headlines and controversy notwithstanding, consider SAVA stock to be one of the more promising biotech plays out there.
Cassava Sciences (SAVA) Stock Pops on Positive Results in Simufilam Trial
SAVA stock jumped 9% on Wednesday after Casava Sciences shared promising results of a clinical trial of its Alzheimer’s treatment.
These Are the Top Reasons You Should Load Up on Cassava Sciences Stock
At the moment, there’s no cure for Alzheimer’s, but Cassava Sciences is working to wipe it out for good making SAVA stock a buy here.
How High Can SAVA Stock Go Once the Controversy Clears?
If a reproduced SEC letter concerning Cassava Sciences’ clearance is legit, SAVA stock could head much higher.
Why Is Cassava Sciences (SAVA) Stock Up 10% Today?
Cassava Sciences has completed part of an important Alzheimer’s disease treatment trial. Here’s why SAVA stock may rise even more soon.
3 Restaurant Stocks to Buy on the Dip: July 2024
These restaurant stocks showing solid same-store sales growth have been unfairly punished in the ongoing correction.
Tread Carefully Before Pulling the Trigger on Cassava Sciences
While SAVA stock is intriguing based on the underlying Alzheimer’s treatment proposal, this market has an extremely high failure rate.
SAVA Stock: Cassava Sciences Extends Simufilam Trials as Much as 36 Months
Cassava Sciences has announced plans to extend trials for its Alzheimer’s treatment drug. This news isn’t helping SAVA stock.
SAVA Stock: What Is Going on With Red-Hot Cassava Sciences Today?
Today, Cassava Sciences initially soared on the announcement of some positive preliminary data, before SAVA stock began selling off.
GRAB Stock: What to Know About the Acquisition Putting Grab in the Spotlight Today
Shares of GRAB stock are in the red after the company announced plans to buy Jaya Grocer, a popular supermarket chain based in Malaysia.
Don’t Let Misconduct Allegations Cloud Your Perception of SAVA Stock
It’s easy to get mired in the controversy surrounding Cassava Sciences, but distracted SAVA stock traders might miss an opportunity.
Does Cassava Sciences and Its Alzheimer’s Drug Really Have What It Takes?
Can Cassava Sciences’ Simufilam drug really treat Alzheimer’s? Who really knows. SAVA stock is pure speculation either way.
What to Do After Cassava Sciences Dropped Off a Cliff
Cassava Sciences posted positive clinical data but triggered a sell on the news event, as SAVA stock short sellers welcomed the drop.
Insiders Like Cassava Sciences, Which Might Be Good News
Insider transactions have historically proven quite prescient for the trajectory of SAVA stock, so what do they imply today?
Twitter Inc (TWTR) Stock Needs a LOT More Than Activist Aid
Jana Partners can’t work miracles with Twitter Inc (TWTR), which is why it took only a small stake and some call options in Twitter stock.
Cassava Sciences News: SAVA Stock Surges 38% on Insider Buying
Cassava Sciences (SAVA) news for Friday concerning insider buying from leaders at the company has SAVA stock on the rise.
SAVA Stock: 12 Things for Investors to Know About Cassava Sciences as Shares Soar
Cassava Sciences (SAVA) stock is on the rise Wednesday after revealing interim results from a recent Alzheimer’s disease clinical trial.
New SAVAW Warrants Are Trading After Cassava Sciences’ Distribution
Following a distribution, investors in Cassava Sciences and SAVA stock now have some warrants to factor into their models today.
9 – 10 of 240 results
